News

Companies hope to combine their cryogenic expertise with dedicated packaging and supply chain services

Containers to potentially be operational by next year, 2024 at the latest

CDMO looks to combat cancer at lower doses

Agency will be reviewing laboratory study and CMC data on the bivalent jab that targets two strains of the SARS-CoV-2 virus

Features an ATP solution to allow for efficiency

CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment

Partnership aims to compare reproducibility and comparability between different suspension bioreactors

New Garner, NC location will be its first outside the Midwest

Endeavor aims to tackle diversity obstacles surrounding this segment, while improving the patient experience

CDMO’s Ireland campus will increase in capacity by 50% as a result

Expanded partnership revolves around hemophilia A therapeutics

Configurable applications address patient and healthcare-provider interfaces, and an analytics dashboard

Will serve as a hub, as company aims for growth in the European region

GMP facility allows for an increase in AAV vector production

Dominance of a handful of integrated firms “at the center of the US pharmaceutical system,” plus their trade practices, will be reviewed

Transaction totals about $3 billion

Project is expected to grow CRDO’s capacity by over 150,000 square feet

Platform delivers intelligent digital twins specifically designed for real-time supply chain operations across the extended enterprise

Facility, with expected completion of 2025, will specialize in mRNA-based therapies

Deal expands CDMO’s presence in Europe

The latest people news happenings over the past month

Goal of ‘Closer to the Formulator’ is to offer a more efficient pharma production process

As a result of new production area, India site’s total production capacity rises from 3 to 4.5 billion doses

Investment will grow manufacturing capabilities at Winchester site

East Syracuse site will serve as a hub for company’s US biologics CDMO business

Should be administered at least five months after the second dose of the two-dose primary series

Deal establishes company’s presence in Mexico

It is the first solution that allows pharma and biotech to design, set up, plan, orchestrate, and scale APT supply chains with one single system, the company reports